The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer ; day:21 ; month:3 ; year:2024 ; pages:1-9
Virchows Archiv ; (21.3.2024), 1-9

Creator: Osakabe, Mitsumasa
Yamada, Noriyuki
Sugimoto, Ryo
Uesugi, Noriyuki
Nakao, Eiichi
Honda, Michitaka
Yanagawa, Naoki
Sugai, Tamotsu

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00428-024-03790-z

URN: urn:nbn:de:101:1-2405230717016.229565710497

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Osakabe, Mitsumasa
Yamada, Noriyuki
Sugimoto, Ryo
Uesugi, Noriyuki
Nakao, Eiichi
Honda, Michitaka
Yanagawa, Naoki
Sugai, Tamotsu
SpringerLink (Online service)

Other Objects (12)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors

TP53 mutations in Romanian patients with colorectal cancer

Expression signatures of TP53 mutations in serous ovarian cancers

Functional classification of TP53 mutations in acute myeloid leukemia

Impact of TP53 mutations in Triple Negative Breast Cancer

Clinical implications of germline mutations in breast cancer: TP53

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors

TP53 mutations in Romanian patients with colorectal cancer

Expression signatures of TP53 mutations in serous ovarian cancers

Functional classification of TP53 mutations in acute myeloid leukemia

Impact of TP53 mutations in Triple Negative Breast Cancer

Clinical implications of germline mutations in breast cancer: TP53

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors

TP53 mutations in Romanian patients with colorectal cancer

Expression signatures of TP53 mutations in serous ovarian cancers

Functional classification of TP53 mutations in acute myeloid leukemia

Impact of TP53 mutations in Triple Negative Breast Cancer

Clinical implications of germline mutations in breast cancer: TP53

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors

TP53 mutations in Romanian patients with colorectal cancer

Expression signatures of TP53 mutations in serous ovarian cancers

Functional classification of TP53 mutations in acute myeloid leukemia

Impact of TP53 mutations in Triple Negative Breast Cancer

Clinical implications of germline mutations in breast cancer: TP53

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors

TP53 mutations in Romanian patients with colorectal cancer

Expression signatures of TP53 mutations in serous ovarian cancers

Functional classification of TP53 mutations in acute myeloid leukemia

Impact of TP53 mutations in Triple Negative Breast Cancer

Clinical implications of germline mutations in breast cancer: TP53

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors

TP53 mutations in Romanian patients with colorectal cancer

Expression signatures of TP53 mutations in serous ovarian cancers

Functional classification of TP53 mutations in acute myeloid leukemia

Impact of TP53 mutations in Triple Negative Breast Cancer

Clinical implications of germline mutations in breast cancer: TP53

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

Related objects

Reset password